- Home
- ANVS vs HLP Comparison
ANVS vs HLP Comparison
Compare ANVS & HLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | HLP |
|---|---|---|
| Founded | 2008 | 2021 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 76.4M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ANVS | HLP |
|---|---|---|
| Price | $1.74 | $0.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 637.0K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $51.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.54 | $0.34 |
| 52 Week High | $5.50 | $1.72 |
Technical Indicators
Market Signals| Indicator | ANVS | HLP |
|---|---|---|
| Relative Strength Index (RSI) | 40.63 | 34.82 |
| Support Level | $1.73 | $0.38 |
| Resistance Level | $2.34 | $0.59 |
| Average True Range (ATR) | 0.12 | 0.08 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 8.22 | 28.53 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
About HLP Hongli Group Inc.
Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.